11 High Growth Healthcare Stocks to Buy Now

8. Legend Biotech Corporation (NASDAQ:LEGN)

Legend Biotech Corporation (NASDAQ:LEGN) is one of the best high growth healthcare stocks to buy now. RBC Capital cut the price target on Legend Biotech Corporation (NASDAQ:LEGN) to $62 from $66 on March 11, reiterating an Outperform rating on the shares. The rating update came after the company released its fiscal Q4 results, telling investors in a research note that it sees a considerable disconnect between the share price and the fundamentals of the business. It added that the management’s execution on several aspects of the Carvykti opportunity has been strong, with factors such as improving real-world safety, impressive Overall Survival data, expanding manufacturing, and consistent double-digit revenue growth.

Legend Biotech Corporation (NASDAQ:LEGN) also received a rating update from Morgan Stanley on March 11. The firm cut the price target on the stock to $49 from $50, reiterating an Overweight rating on the shares and telling investors that it updated estimates after the company released its fiscal Q4 financial report. It, however, added that the firm is awaiting additional data from the CARTITUDE-5 study and the earlier-stage in vivo pipeline this year.

Legend Biotech Corporation (NASDAQ:LEGN) is a clinical-stage company that develops, discovers, manufactures, and commercializes novel therapies for oncology and other indications. It develops advanced cell therapies across an elaborate range of technology platforms. The company operates in the US, China, and other geographical segments.